DaVita (NYSE:DVA) Announces Earnings Results

DaVita (NYSE:DVA) released its quarterly earnings data on Thursday. The company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10, Zacks reports. DaVita had a return on equity of 88.18% and a net margin of 6.53%.

DaVita Stock Performance

NYSE:DVA traded up $5.45 during midday trading on Thursday, reaching $177.45. The stock had a trading volume of 1,007,710 shares, compared to its average volume of 577,648. The stock has a market capitalization of $14.55 billion, a P/E ratio of 19.14, a PEG ratio of 0.84 and a beta of 0.94. DaVita has a 1-year low of $118.56 and a 1-year high of $179.60. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33. The firm’s fifty day simple moving average is $161.15 and its 200-day simple moving average is $157.11.

Analysts Set New Price Targets

Separately, Barclays boosted their price target on DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 31st. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $161.80.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.